OLMA: Form 144 filed for proposed sale of 20,000 shares

OLMA filer submitted a Form 144 reporting a proposed sale of 20,000 common shares by Fidelity Brokerage Services LLC.

Rhea-AI Filing Summary

OLMA filer submitted a Form 144 reporting a proposed sale of 20,000 common shares by Fidelity Brokerage Services LLC. The filing also discloses recent reported sales by Shane W. Kovacs, including a sale of 100,000 shares for $2,873,214.99 on 01/15/2026 and 10,000 shares for $238,498.19 on 02/12/2026.

Insights

Securities Compliance Analyst

Form 144 notifies the market of a proposed transfer of restricted/controlled shares.

The filing lists a proposed sale of 20,000 common shares by Fidelity Brokerage Services LLC and documents prior transactions by Shane W. Kovacs on 01/13/2026, 01/15/2026, and 02/12/2026, with amounts tied to each sale.

Regulatory impact depends on whether the proposed sale complies with Section 144 conditions; subsequent filings or broker reports will show execution details and timing.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does OLMA's Form 144 report?

It reports a proposed sale of 20,000 common shares by Fidelity Brokerage Services LLC. The filing lists prior sales by Shane W. Kovacs on 01/13/2026, 01/15/2026, and 02/12/2026.

Who is listed as the proposed seller in the OLMA Form 144?

The proposed seller is Fidelity Brokerage Services LLC, for 20,000 common shares. The filing also shows prior reported dispositions by Shane W. Kovacs with dates and dollar amounts.

What prior insider sales are disclosed in this filing for OLMA?

The filing discloses Shane W. Kovacs sold 3,822 shares on 01/13/2026, 100,000 shares on 01/15/2026 for $2,873,214.99, and 10,000 shares on 02/12/2026 for $238,498.19.

Does the Form 144 show the sale has occurred for OLMA shares?

No; Form 144 notifies an intent to sell under Section 144 and includes proposed quantities. Execution details and settlement timing are not shown in this filing and require later transaction reports or broker confirmations.

How does Form 144 affect trading visibility for OLMA?

Form 144 provides public notice of proposed sales of restricted/controlled shares, such as the 20,000 shares listed here. Actual market impact depends on whether and when the sales are executed and reported.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/23/2026 - 02:34 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001579397
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Olema Pharmaceuticals, Inc.
SEC File Number	001-39712
Address of Issuer	780 BRANNAN STREET SAN FRANCISCO CALIFORNIA 94103
Phone	(415) 651-3316
Name of Person for Whose Account the Securities are To Be Sold	Kovacs Shane William Charles
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Former Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	20000	480007.00	68659923	02/23/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/15/2020	Restricted Stock Vesting	Issuer			20000	06/15/2020	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Shane W. Kovacs 780 Brannan Street San Francisco CA 94103	Common	01/13/2026	3822	107069.20
Shane W. Kovacs 780 Brannan Street San Francisco CA 94103	Common	01/15/2026	100000	2873214.99
Shane W. Kovacs 780 Brannan Street San Francisco CA 94103	Common	02/12/2026	10000	238498.19

144: Remarks and Signature

Remarks
Date of Notice	02/23/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Jennifer Ruchti, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Shane W. Kovacs
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)